新冠疫情期间基于微信平台的女性皮下抗凝患者远程护理指导：一项回顾性分析。
Remote care instruction the WeChat platform for female patients receiving subcutaneous anticoagulation during the COVID-19 pandemic: a retrospective analysis.
机构信息
Vascular Surgery & Interventional Medicine, Fujian Maternity and Child Health Hospital, Fuzhou, Fujian, China.
College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, China.
出版信息
PeerJ. 2024 Oct 24;12:e18337. doi: 10.7717/peerj.18337. eCollection 2024.
BACKGROUND
The purpose of this study was to estimate the effect of remote nursing guidance based on WeChat platform for female patients receiving subcutaneous anticoagulation during the COVID-19 epidemic.
METHODS
Retrospective analysis of clinical data, including demographic data and anticoagulation complications, of 126 female patients who received subcutaneous anticoagulation therapy and received remote nursing guidance using WeChat platform in our hospital from January 2022 to December 2022. The Anti-Clot Treatment Scale (ACTS) and the World Health Organization Quality of Life-BREF (WHOQOL-BREF) scale were used to evaluate patients' satisfaction with anticoagulation and quality of life at the beginning of anticoagulation, half a month after anticoagulation, and after three months of anticoagulation.
RESULTS
In total, 126 patients were involved in this study, all of them were female, 115 cases were natural pregnancy, 11 cases were assisted reproduction. This study included seven cases of lower extremity deep vein thrombosis, 100 cases of hypercoagulable state, 10 cases of antiphospholipid syndrome, and eight cases of protein S deficiency, one case of hyperhomocysteinemia. During the follow-up period, four patients (3.17%) had subcutaneous injection complications, including three cases of subcutaneous hemorrhage and one case of liquid leakage. A total of 123 patients had completed the planned anticoagulation therapy or were receiving anticoagulation therapy as planned, and three patients did not receive anticoagulation therapy as planned (zero cases lost contact, two cases changed treatment units, and one case refused treatment). ACTS score (55.03 ± 1.73) and WHOQOL-BREF score (62.18 ± 3.17) after three months of anticoagulation, ACTS score (54.18 ± 1.20) and WHOQOL-BREF score (60.37 ± 2.25) after half a month of anticoagulation was significantly higher than the ACTS score (47.81 ± 1.69) and WHOQOL-BREF score (55.25 ± 1.85) at the beginning of anticoagulation, and the difference was statistically significant ( value < 0.01).
CONCLUSIONS
During the COVID-19 pandemic, remote nursing instruction the WeChat platform for female patients receiving subcutaneous anticoagulation can increase anticoagulation compliance, satisfaction, and quality of life.
背景
本研究旨在评估基于微信平台对 COVID-19 疫情期间接受皮下抗凝治疗的女性患者进行远程护理指导的效果。
方法
回顾性分析 2022 年 1 月至 2022 年 12 月我院 126 例接受皮下抗凝治疗并通过微信平台接受远程护理指导的女性患者的临床资料，包括人口统计学数据和抗凝并发症。采用抗栓治疗量表（ACTS）和世界卫生组织生活质量简表（WHOQOL-BREF）量表评估患者抗凝治疗开始时、抗凝治疗半个月后和三个月后的满意度和生活质量。
结果
本研究共纳入 126 例患者，均为女性，自然妊娠 115 例，辅助生殖 11 例。本研究包括下肢深静脉血栓形成 7 例，高凝状态 100 例，抗磷脂综合征 10 例，蛋白 S 缺乏症 8 例，高同型半胱氨酸血症 1 例。随访期间，4 例（3.17%）患者出现皮下注射并发症，包括皮下出血 3 例，液体渗漏 1 例。共有 123 例患者完成了计划的抗凝治疗或正在按计划接受抗凝治疗，3 例患者未按计划接受抗凝治疗（无失联病例，2 例更换治疗单位，1 例拒绝治疗）。抗凝治疗 3 个月后 ACTS 评分（55.03±1.73）和 WHOQOL-BREF 评分（62.18±3.17），抗凝治疗半个月后 ACTS 评分（54.18±1.20）和 WHOQOL-BREF 评分（60.37±2.25）均明显高于抗凝治疗开始时的 ACTS 评分（47.81±1.69）和 WHOQOL-BREF 评分（55.25±1.85），差异有统计学意义（ 值<0.01）。
结论
在 COVID-19 大流行期间，通过微信平台对接受皮下抗凝治疗的女性患者进行远程护理指导可以提高抗凝治疗的依从性、满意度和生活质量。
Zotero 插件